Investing.com - Amryt Pharma Holdings reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Amryt Pharma Holdings announced earnings per share of $-0.06 on revenue of $61.13M. Analysts polled by Investing.com anticipated EPS of $-0.02 on revenue of $67.61M.
Amryt Pharma Holdings shares are down 58% from the beginning of the year and are trading at $6.90 , down-from-52-week-high.
Amryt Pharma Holdings follows other major Healthcare sector earnings this month
Amryt Pharma Holdings's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar